Regulus Therapeutics Inc. (RGLS)
Jun 25, 2025 - RGLS was delisted (reason: acquired by Novartis)
8.16
+0.02 (0.25%)
Inactive · Last trade price
on Jun 24, 2025
Regulus Therapeutics Employees
Regulus Therapeutics had 34 employees as of December 31, 2024. The number of employees increased by 4 or 13.33% compared to the previous year.
Employees
34
Change (1Y)
4
Growth (1Y)
13.33%
Revenue / Employee
n/a
Profits / Employee
-$1,397,735
Market Cap
n/a
Employees Chart
RGLS News
- 2 days ago - Novartis completes acquisition of Regulus Therapeutics - GlobeNewsWire
- 3 days ago - Novartis announces expiration of Regulus Therapeutics tender offer - GlobeNewsWire
- 4 weeks ago - Novartis announces commencement of tender offer to acquire Regulus Therapeutics - GlobeNewsWire
- 7 weeks ago - Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates - PRNewsWire
- 7 weeks ago - REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS - Business Wire
- 2 months ago - Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher - Benzinga
- 2 months ago - Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million - Benzinga
- 2 months ago - Novartis to Acquire Regulus in $1.7 Billion Deal - WSJ